Immuno-oncology market to hit $185.69 billion by 2035.

The global immuno-oncology market is expected to grow from $35 billion to $185.69 billion by 2035. The genomics revolution is driving this growth, integrating advanced profiling into oncology workflows to identify winning treatments. Oncolytics Biotech, ImmunityBio, OS Therapies, BioNTech, and Compass Therapeutics are among the companies benefiting from this trend. The precision medicine market is projected to reach $537.17 billion by 2035, with investors flocking to targeted therapeutic platforms. FDA accelerated approval frameworks are also serving as a catalyst for growth in the sector.